S. Zhuplatov

发表

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial

T. Mansfield, R. Henry, A. Katz, 2018, Diabetes technology & therapeutics.

An obesity therapeutic treatment as a modern pharmaceutical industry challenge

S. Zhuplatov, 2015 .

Protein Phosphorylation in Irradiated Human Melanoma Cells

S. Leachman, R. Warters, Dustin L. Williams, 2007, Radiation research.

Removal of Endotoxins and Cytokines by Plasmapheresis Filtration with Plasma Exchange Therapy (TPE) Could Benefit Patients with Covid-19 in Critical Condition

S. Zhuplatov, 2020, Journal of Anesthesia and Intensive Care Medicine.

Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.

D. Blumenthal, A. Cheung, S. Zhuplatov, 2006, Basic & clinical pharmacology & toxicology.

The nuclear matrix shell proteome of human epidermis.

P. Cassidy, S. Leachman, R. Warters, 2010, Journal of dermatological science.

Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.

A. Cheung, Steven Edward Kern, S. W. Kim, 2004, Kidney international.

Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis.

D. Blumenthal, A. Cheung, Steven Edward Kern, 2006, Kidney international.

Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled trial

J. Frias, J. Ruggles, E. Klein, 2016, Diabetes, obesity & metabolism.